🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective was to evaluate the persistence of bactericidal antib...
Status
Completed
Location
Alabama Clinical Therapeutics 806 St. Vincent's Drive, Suite 615
Start Date
2010-07
Trial ID
NCT01148017
Treatments Being Tested
The purpose/aim of this study is to assess the safety and antibody response...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-12-08
Trial ID
NCT02986854
The purpose of the study was to evaluate the immunogenicity and describe th...
Status
Completed
Location
Investigational Site
Start Date
2017-02-17
Trial ID
NCT03077438
In this extension study, V59P20E1, the sponsor was planning to assess 5-yea...
Status
Completed
Location
82 Children s Inv Research Prgm (ChIRP) 2900 Medical Center Parkway, Ste. 300
Start Date
2013-05
Trial ID
NCT01823536
Treatments Being Tested
The purpose of this study was to compare the immunogenicity and describe th...
Status
Completed
Location
Birmingham Pediatric Associates Site Number : 8400026
Start Date
2018-04-25
Trial ID
NCT03537508
Primary Objective: 1. To describe the vaccine seroprotection (antibody tit...
Status
Completed
Location
Investigational Site Number :4840001
Start Date
2018-10-17
Trial ID
NCT03630705
Treatments Being Tested
The primary objective of this study is to demonstrate the non-inferiority o...
Status
Completed
Location
Alabama Clinical Therapeutics Site Number : 8400036
Start Date
2018-10-04
Trial ID
NCT03691610
Treatments Being Tested
The purpose of the study was to assess the immunogenicity and safety of two...
Status
Completed
Location
06 Kosin University Gospel Hospital 34, amnam-dong
Start Date
2013-11
Trial ID
NCT01973218
The primary objective of this study was to describe the safety profile of M...
Status
Completed
Location
Birmingham Pediatric Associates-Site Number:8400049
Start Date
2018-09-17
Trial ID
NCT03673462
Treatments Being Tested
This study will evaluate the safety and immunogenicity of combination vacci...
Status
Completed
Location
Alabama Clinical Therapeutics, 806 St. Vincent's Drive, Suite 615
Start Date
2011-08
Trial ID
NCT01272180
Treatments Being Tested